These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34749478)

  • 21. Changes in chronic disease management among community health centers (CHCs) in China: Has health reform improved CHC ability?
    Wang Z; Shi J; Wu Z; Xie H; Yu Y; Li P; Liu R; Jing L
    Int J Health Plann Manage; 2017 Jul; 32(3):317-328. PubMed ID: 28639364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Pathway of China's Integrated Delivery System: Based on the Analysis of the Medical Consortium Policies.
    Gao H; Du XL; Liao JZ; Xiang L
    Curr Med Sci; 2022 Dec; 42(6):1164-1171. PubMed ID: 36245032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Policy experimentation and innovation as a response to complexity in China's management of health reforms.
    Husain L
    Global Health; 2017 Aug; 13(1):54. PubMed ID: 28774319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of China's 2009 healthcare reform on the utilisation of continuum of care for maternal health services: evidence from two cross-sectional household surveys in Shaanxi Province.
    Fan X; Kumar MB; Zhou Z; Lee CH; Wang D; Liu H; Dang S; Gao J
    Int J Equity Health; 2020 Jun; 19(1):100. PubMed ID: 32560727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficiency of provincial government health care expenditure after China's new health care reform.
    Guo X; Zhang J; Xu Z; Cong X; Zhu Z
    PLoS One; 2021; 16(10):e0258274. PubMed ID: 34644313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health promotion interventions and policies addressing excessive alcohol use: a systematic review of national and global evidence as a guide to health-care reform in China.
    Li Q; Babor TF; Zeigler D; Xuan Z; Morisky D; Hovell MF; Nelson TF; Shen W; Li B
    Addiction; 2015 Jan; 110 Suppl 1(0 1):68-78. PubMed ID: 25533866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health care in China: improvement, challenges, and reform.
    Wang C; Rao K; Wu S; Liu Q
    Chest; 2013 Feb; 143(2):524-531. PubMed ID: 23381317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergency medicine in China: A review of the history of progress and current and future challenges after 40 years of reform.
    Shi X; Bao J; Zhang H; Wang H; Wang Y; Li L; Hou P
    Am J Emerg Med; 2020 Mar; 38(3):662-669. PubMed ID: 31902696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Persistence and Change in China's Healthcare Insurance Reform: Clues from Fiscal Subsidy Policies Made for Settling COVID-19 Patients' Medical Costs.
    Ma T; Guo B; Xu J
    Risk Manag Healthc Policy; 2022; 15():1129-1144. PubMed ID: 35637742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hospital of the future in China: China's reform of public hospitals and trends from industrialized countries.
    Barber SL; Borowitz M; Bekedam H; Ma J
    Health Policy Plan; 2014 May; 29(3):367-78. PubMed ID: 23612847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Problems and challenges: development of blood transfusion services in Mainland China within the context of health-care system reform.
    Chen J; Ou-Yang J; Xie G; Liang H; Fan Y; Gao R; Li S; Rong X; He B; Bei C; Fu Y
    Transfus Med; 2019 Aug; 29(4):253-261. PubMed ID: 31359545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From Mao to McDonaldization? Assessing the rationalisation of health care in China.
    Millar R
    Sociol Health Illn; 2021 Aug; 43(7):1643-1659. PubMed ID: 34382703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited effects of the comprehensive pricing healthcare reform in China.
    Wang Y; Zhang Y; Ma C; Jiang Y; Li Y; Wang X; Ma S
    Public Health; 2019 Oct; 175():4-7. PubMed ID: 31369975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Hybrid' top down bottom up health system innovation in rural China: A qualitative analysis.
    Klundert JV; de Korne D; Yuan S; Wang F; van Wijngaarden J
    PLoS One; 2020; 15(10):e0239307. PubMed ID: 33027287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transformation of health care in China.
    Hsiao WC
    N Engl J Med; 1984 Apr; 310(14):932-6. PubMed ID: 6700690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Mixed Effect of China's New Health Care Reform on Health Insurance Coverage and the Efficiency of Health Service Utilisation: A Longitudinal Approach.
    Chen J; Xu S; Gao J
    Int J Environ Res Public Health; 2020 Mar; 17(5):. PubMed ID: 32182950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary health care in China: is China's health reform reform for the whole nation?
    Cheng JM; Yuan YX; Lu W; Yang L
    Prim Health Care Res Dev; 2017 Jul; 18(4):398-403. PubMed ID: 28290254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does economic incentive matter for rational use of medicine? China's experience from the essential medicines program.
    Chen M; Wang L; Chen W; Zhang L; Jiang H; Mao W
    Pharmacoeconomics; 2014 Mar; 32(3):245-55. PubMed ID: 23813440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in health expenditures in China in 2000s: has the health system reform improved affordability.
    Long Q; Xu L; Bekedam H; Tang S
    Int J Equity Health; 2013 Jun; 12():40. PubMed ID: 23764104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early appraisal of China's huge and complex health-care reforms.
    Yip WC; Hsiao WC; Chen W; Hu S; Ma J; Maynard A
    Lancet; 2012 Mar; 379(9818):833-42. PubMed ID: 22386036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.